SCHEMBL1864665

SCHEMBL1864665

CC(C)(C)OC(=O)n1cccc2c3ccccc3cc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
PIK3R1 P27986 1/20 0.44
PIK3CA P42336 1/20 0.44
NR1H2 P55055 10/20 0.41
BUB1 O43683 1/20 0.40
BCHE P06276 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
NR1H3 Q13133 3/20 0.39
TNK2 Q07912 1/20 0.39
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
ATR Q13535 1/20 0.38
PIM1 P11309 1/20 0.38
MARK3 P27448 1/20 0.38
MAP4K2 Q12851 1/20 0.38
CAMK2B Q13554 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28460770 0.86 HSP90AA1 (0.49) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL23303434 0.84 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL29780523 0.84 HSP90AA1 (0.52) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL22036737 0.81 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL6027788 0.77 NR1H2 (0.45) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL18812369 0.76 HSP90AA1 (0.49) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL14770871 0.75 HSP90AA1 (0.49) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL26819799 0.75 PIK3R1 (0.54) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2
SCHEMBL24697208 0.75 HSP90AA1 (0.48) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL15417099 0.74 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3R1PIK3CANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635563-A1 CRYSTALLINE FORMS OF HYDROCHLORIDE SALT OF (4A-R,9A-S) -1- (1H - BENZOIMIDAZOLE- 5 -CARBONYL) -2, 3, 4, 4A, 9, 9A - HEXAHYDRO -1H- INDENO [2, 1 -B]PYRIDINE- 6 -CARBONITRILE AND THEIR USE AS HSD 1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2013-09-11 EP disclosed
EP-2496559-A1 ARYL- AND HETEROARYLCARBONYL DERIVATIVES OF HEXAHYDROINDENOPYRIDINE AND OCTAHYDROBENZOQUINOLINE Vitae Pharmaceuticals, Inc. (US) 2012-09-12 EP disclosed
WO-2012061708-A1 CRYSTALLINE FORMS OF HYDROCHLORIDE SALT OF (4A-R,9A-S) -1- (1H - BENZOIMIDAZOLE- 5 -CARBONYL) -2, 3, 4, 4A, 9, 9A - HEXAHYDRO -1H- INDENO [2, 1 -B] PYRIDINE- 6 -CARBONITRILE AND THEIR USE AS HSD 1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-10 WO disclosed
WO-2011057054-A1 ARYL- AND HETEROARYLCARBONYL DERIVATIVES OF HEXAHYDROINDENOPYRIDINE AND OCTAHYDROBENZOQUINOLINE VITAE PHARMACEUTICALS, INC. (US) 2011-05-12 WO disclosed